Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1525.2% | +1770.1% | 3 / 3 | +20.0% | +5.78 pp | +14.56 pp | +59.1% | 2.67 | 35.88 | 3.087 | +20,0% | 467 | +3.090,6% | 35.88 | -9.50 | — |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | -4 | 8 | |||||||
Valuation annotation:Price: 560.200 (close price on 2026-10-19)EPS (TTM): 15.613
Financial charts
1.Revenue & growth
VND bn3.087Q2/26
1.Revenue & growth
VND bn3.087Q2/26
2.Profit & growth
VND bn477Q2/26
3.Profit mix (Penman)
VND bn533Q2/26
4.Margins & cost structure
%39.0%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn1.734Q2/26
7.Asset structure
VND bn11.612Q2/26
8.Funding & debt health
VND bn · times11.612Q2/26
9.Revenue backlog
VND bn3.380Q2/26
10.Valuation
times · %35,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %16.058Q2/26
Adjusted EPS growth, latest quarter
16,3× higher
Average adjusted EPS growth, 3 quarters
16,3× higher
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
1.2%
Source: vnstockData through Q2/26